[{"address1": "100 Palmetto Park Place", "city": "Ponte Vedra", "state": "FL", "zip": "32081", "country": "United States", "phone": "904 373 5940", "website": "https://www.treace.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible correction of metatarsus adductus deformities and osteoarthritis of the midfoot. It serves physicians, surgeons, ambulatory surgery centers and hospitals related to the surgical management of bunion and related midfoot deformities. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.", "fullTimeEmployees": 477, "companyOfficers": [{"maxAge": 1, "name": "Mr. John T. Treace", "age": 52, "title": "Founder, Chairman & CEO", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 828346, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark L. Hair CPA", "age": 54, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 531907, "exercisedValue": 0, "unexercisedValue": 859289}, {"maxAge": 1, "name": "Mr. Scot M. Elder J.D.", "age": 49, "title": "Chief Legal & Compliance Officer and Corporate Secretary", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 565557, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sean F. Scanlan Ph.D.", "age": 42, "title": "Chief Innovation Officer", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 457834, "exercisedValue": 167495, "unexercisedValue": 2432350}, {"maxAge": 1, "name": "Mr. Gaetano M. Guglielmino", "age": 54, "title": "Chief Commercial Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 137338, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Terry W. Lubben", "age": 59, "title": "Chief Operations & Supply Chain Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Taylor  Erickson", "title": "Chief Information & Cybersecurity Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brad  Barr", "title": "Senior Vice President of Sales", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Daniel E. Owens", "age": 52, "title": "Chief Human Resources Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shana  Zink", "title": "Senior Vice President of Clinical Affairs & Reimbursement", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 8, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1751328000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.79, "open": 5.83, "dayLow": 5.645, "dayHigh": 5.975, "regularMarketPreviousClose": 5.79, "regularMarketOpen": 5.83, "regularMarketDayLow": 5.645, "regularMarketDayHigh": 5.975, "payoutRatio": 0.0, "beta": 0.691, "forwardPE": -7.6, "volume": 236847, "regularMarketVolume": 236847, "averageVolume": 387095, "averageVolume10days": 218500, "averageDailyVolume10Day": 218500, "bid": 5.65, "ask": 5.71, "bidSize": 2, "askSize": 2, "marketCap": 358558496, "fiftyTwoWeekLow": 4.54, "fiftyTwoWeekHigh": 10.79, "priceToSalesTrailing12Months": 1.7007883, "fiftyDayAverage": 5.9652, "twoHundredDayAverage": 7.28505, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 351833216, "profitMargins": -0.25135002, "floatShares": 47098825, "sharesOutstanding": 62905000, "sharesShort": 2743352, "sharesShortPriorMonth": 2787389, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0436, "heldPercentInsiders": 0.25814, "heldPercentInstitutions": 0.61974, "shortRatio": 8.91, "shortPercentOfFloat": 0.0575, "impliedSharesOutstanding": 62905000, "bookValue": 1.675, "priceToBook": 3.402985, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -52989000, "trailingEps": -0.85, "forwardEps": -0.75, "enterpriseToRevenue": 1.669, "enterpriseToEbitda": -7.946, "52WeekChange": -0.21703297, "SandP52WeekChange": 0.16932249, "quoteType": "EQUITY", "currentPrice": 5.7, "targetHighPrice": 14.5, "targetLowPrice": 6.6, "targetMeanPrice": 9.78333, "targetMedianPrice": 9.0, "recommendationMean": 2.33333, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 76089000, "totalCashPerShare": 1.21, "ebitda": -44278000, "totalDebt": 69364000, "quickRatio": 3.249, "currentRatio": 4.504, "totalRevenue": 210819008, "debtToEquity": 65.847, "revenuePerShare": 3.382, "returnOnAssets": -0.1456, "returnOnEquity": -0.45733002, "grossProfits": 169176000, "freeCashflow": -17027876, "operatingCashflow": -25748000, "revenueGrowth": 0.029, "grossMargins": 0.80247, "ebitdaMargins": -0.21003, "operatingMargins": -0.29639998, "financialCurrency": "USD", "symbol": "TMCI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Treace Medical Concepts, Inc.", "corporateActions": [], "postMarketTime": 1753474319, "regularMarketTime": 1753473600, "longName": "Treace Medical Concepts, Inc.", "marketState": "CLOSED", "regularMarketChangePercent": -1.55441, "regularMarketPrice": 5.7, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1619184600000, "postMarketChangePercent": 0.0, "postMarketPrice": 5.7, "postMarketChange": 0.0, "regularMarketChange": -0.0900002, "regularMarketDayRange": "5.645 - 5.975", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 387095, "fiftyTwoWeekLowChange": 1.1599998, "fiftyTwoWeekLowChangePercent": 0.25550658, "fiftyTwoWeekRange": "4.54 - 10.79", "fiftyTwoWeekHighChange": -5.09, "fiftyTwoWeekHighChangePercent": -0.4717331, "fiftyTwoWeekChangePercent": -21.703297, "earningsTimestamp": 1754596800, "earningsTimestampStart": 1754596800, "earningsTimestampEnd": 1754596800, "earningsCallTimestampStart": 1754598600, "earningsCallTimestampEnd": 1754598600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.85, "epsForward": -0.75, "epsCurrentYear": -0.79573, "priceEpsCurrentYear": -7.1632338, "exchange": "NMS", "messageBoardId": "finmb_282593338", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -0.26520014, "fiftyDayAverageChangePercent": -0.04445788, "twoHundredDayAverageChange": -1.5850501, "twoHundredDayAverageChangePercent": -0.21757574, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-04-23", "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "displayName": "Treace Medical Concepts", "trailingPegRatio": null, "__fetch_time": "2025-07-26"}]